Inotek Pharmaceuticals CEO Gaurav Shah's 2019 pay falls 39% to $3.9M
Inotek Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 24, 2020
Inotek Pharmaceuticals reported fiscal year 2019 executive compensation information on April 24, 2020.
In 2019, three executives at Inotek Pharmaceuticals received on average a compensation package of $2.9M, a 14% decrease compared to previous year.
Average pay of disclosed executives at Inotek Pharmaceuticals
Gaurav D. Shah, Chief Executive Officer, received $3.9M in total, which decreased by 39% compared to 2018. 78% of Shah's compensation, or $3M, was in option awards. Shah also received $349K in bonus, $480K in salary, as well as $11K in other compensation.
Kinnari Patel, Chief Operating Officer, received a compensation package of $2.8M, which decreased by 7% compared to previous year. 75% of the compensation package, or $2.1M, was in option awards.
Kamran Alam, Senior Vice President – Finance and Principal Financial Officer, earned $2.1M in 2019.
Related executives
You may also like
Source: SEC filing on April 24, 2020.